Back to Search
CONSTANTINE LOGOTHETIS, MD
MD
Hematology & Oncology Physician
NPI: 1598225567IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
74165(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
The role of caveolin-1 in prostate cancer: clinical implications.
PMID 19581923·Prostate Cancer Prostatic Dis·2010
6-review
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.
PMID 19276258·Clin Cancer Res·2009
3-trial
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
PMID 19244175·J Natl Cancer Inst·2009
3-trial
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
PMID 19338544·BJU Int·2009
8-other
Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer.
PMID 19414670·J Clin Oncol·2009
3-trial
GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.
PMID 19652704·PLoS One·2009
8-other
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.
PMID 19213669·Clin Genitourin Cancer·2009
8-other
Prostate cancer: thalidomide for prostate cancer: is there progress?
PMID 19424170·Nat Rev Urol·2009
8-other
Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.
PMID 19202079·Proc Natl Acad Sci U S A·2009
8-other
Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity.
PMID 19106640·Cancer Biol Ther·2009
8-other
Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data.
PMID 19653896·BMC Med Genomics·2009
8-other
High-grade prostate cancer and the prostate cancer prevention trial.
PMID 19138948·Cancer Prev Res (Phila)·2008
8-other
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.
PMID 18618013·J Clin Invest·2008
7-preclinical
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis.
PMID 19018165·Cancer Biol Ther·2008
8-other
Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer.
PMID 18841158·Br J Cancer·2008
8-other
CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients.
PMID 18818309·Proc Natl Acad Sci U S A·2008
2-rct
Cadherin-11 promotes the metastasis of prostate cancer cells to bone.
PMID 18708358·Mol Cancer Res·2008
7-preclinical
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
PMID 19029421·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2004 HAYES ST STE 800
NASHVILLE, TN 37203 - Phone
- (877) 836-6662
Quick Facts
- NPI
- 1598225567
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile